Concept Medical Inc. products

AN EXCELLENT ALTERNATIVE FOR REVASCULAZATION OF SFA AND BTK ARTERIES.MagicTouch PTA is intended to prevent re-narrowing of superficial femoral and popliteal arteries in patients with peripheral artery disease

A functioning dialysis access (AVF/AVG) is critical to the delivery of life saving hemodialysis therapy in patients with End Stage Renal Failure. PROMISING REVASCULARIZATION THERAPY FOR DYSFUNCTIONAL DIALYSIS FISTULA . MagicTouch AVF is intended for stenotic lesions of dysfunctional arteriovenous fistula and graft.

Erectile dysfunction (ED) is de?ned as the recurrent inability to achieve and maintain an erection satisfactory for sexual intercourse.

Drug is coated on the abluminal side only. Leading to mono directional drug release & less systemic exposure of drug which leads to faster healing

Conversion of Sirolimus drug into sub-micron sized particles; Nanocarriers created by encapsulation of sub-micron sized Sirolimus drug into highly biocompatible drug Carrier-phospholipid; Upon inflation of MagicTouch SCB at target site, nanocarriers with Sirolimus drug inside gets transferred to the vessel wall following the principle of co-efficient diffusion; Upon body pH variation, nanocarriers mimics the body lipids and liberates Sirolimus; The sub-micron sized Sirolimus drug particles penetrate the deepest layer of the vessel over a period.

Conversion of Sirolimus drug into sub-micron sized particles; Nanocarriers created by encapsulation of sub-micron sized Sirolimus drug into highly biocompatible drug Carrier-phospholipid; Encapsulated Sirolimus is coated on stent and parts of balloon; Upon implantation of Abluminus NP at target site, Nanocarriers with Sirolimus drug from stent and parts of balloon get transferred to the vessel wall following the principle of co-efficient diffusion; Upon body pH variation, Nanocarriers mimics the body lipids and liberates Sirolimus; The sub-micron sized Sirolimus drug particles penetrate the deepest layer of the vessel over a period.